Actively Recruiting
Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders
Led by Centre Hospitalier Departemental Vendee · Updated on 2025-09-23
90
Participants Needed
4
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Trigger finger is a mechanical problem characterized by pain and catching of digit in flexion. Histological changes of A1 pulley and synovial proliferation have been identified as factors that prompt trigger finger The first-line treatment of trigger finger is conservative with splinting and corticosteroid injection. If the first infiltration fails, either a second infiltration or surgical sectioning of the pulley is proposed. Surgery can be performed by several techniques (open section, percutaneous section with palpatory guidance, or under ultrasound guidance). Percutaneous A1 pulley release under ultrasound guidance consists of cutting the A1 pulley by a percutaneous insertion with small needle under local anaesthesia. The hypothesis of the study is that percutaneous A1 pulley release under ultrasound guidance followed by a corticosteroid injection would be more effective than a second corticosteroid injection alone on complete resolution of the trigger finger symptoms
CONDITIONS
Official Title
Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient 18 years old or older
- Trigger finger in thumb or long fingers requiring treatment
- Quinnell score greater than 1
- Trigger finger episode confirmed by history or clinical exam
- Failure of a first corticosteroid injection more than 3 months before joining
- First corticosteroid injection within 15 months before joining
- A1 pulley thickening on ultrasound of 0.5 mm or more
- Ability to understand the study and provide consent
- Covered by social security
You will not qualify if you...
- Multiple symptomatic fingers needing ultrasound-guided pulley release
- Pregnant, breastfeeding, or potential to become pregnant without contraception
- Known allergy to corticosteroids or lidocaine
- On anticoagulant medications
- Local or general infections or suspected infections
- Current live vaccines
- Active viral infections (hepatitis, herpes, varicella, shingles)
- Severe or uncontrolled high blood pressure
- Uncontrolled diabetes
- Progressive cardiovascular disease
- On hemodialysis
- Finger prosthesis on the affected finger
- Tendon fissure seen on ultrasound
- Inflammatory diseases with tenosynovitis (e.g., rheumatoid arthritis)
- Previous finger surgery
- Dupuytren's disease
- Participating in another interventional drug or device trial
- Under legal guardianship or protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Hopital Henri Mondor
Créteil, France, 94000
Actively Recruiting
2
CHD Vendée
La Roche-sur-Yon, France, 85925
Actively Recruiting
3
CHU Nantes
Nantes, France, 44000
Actively Recruiting
4
Hopital Lariboisière
Paris, France, 75010
Actively Recruiting
Research Team
C
Clémentin GABORIAU
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here